Novo Nordisk Puts $2.3bn Into Manufacturing, But Won’t Aid Wegovy Supply Woes

12 Jun 2023

Company says its new API production facility in Denmark will come online in 2029 and help meet demand for pipeline products in serious chronic diseases. Novo is currently contending with supply crunches for its semaglutide products.

Manufacturing — Novo Nordisk is adding to its API manufacturing capacity in Denmark • Source: Shutterstock

Novo Nordisk Puts $2.3bn Into Manufacturing, But Won’t Aid Wegovy Supply Woes

More from Manufacturing

More from Business